logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 [see all tables in this series...]

Part (v) Percentage distribution of new inpatient clients by age group for each primary drug

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opioids0.06.027.031.716.610.05.13.528.930785
Cocaine0.07.920.526.024.612.65.53.029.63660
Stimulants0.222.932.519.29.18.13.24.826.3106514
Hypnotics and sedatives0.67.09.114.617.012.99.429.535.71024151
Hallucinogens9.741.929.016.13.20.00.00.020.7310
Volatile substances8.347.624.412.62.42.00.82.021.22544
Cannabis 2.331.730.417.58.84.72.12.524.213060
Other substances 9.228.29.211.19.56.67.219.0293052
Total1.215.724.823.213.88.94.87.628.47429176

Notes:

 The countries supplying data are: 

 BG, CZ, DK, IE, GR, CY, HU, AT, RO, SK, FI, SE, UK, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008